The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Management of Bleeding in Patients with Advanced Cancer
Open accessAbstract
Learning Objectives: After completing this course, the reader will be able to: List at least four local hemostatic agents and dressings for controlling localized bleeding in a patient with cancer. List at least four systemic therapies for controlling bleeding in a patient with advanced cancer. Describe a decision-making process related to managing bleeding in an end-of-life cancer patient. Access and take the CME test online and receive 1 hour of AMA PRA category 1 credit at CME.TheOncologist.com Bleeding occurs in up to 10% of patients with advanced cancer. It can present in many different ways. This article provides a qualitative review of treatment options available to manage visible bleeding. Local modalities, such as hemostatic agents and dressings, radiotherapy, endoscopic ligation and coagulation, and transcutaneous arterial embolization, are reviewed in the context of advanced cancer, as are systemic treatments such as vitamin K, vasopressin/desmopressin, octreotide/somatostatin, antifibrinolytic agents (tranexamic acid and aminocaproic acid), and blood products. Considerations at the end of life are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Oxford Textbook of Palliative Medicine
(2009) · Oxford University Press eBooks · doi:10.1093/med/9780198570295.001.0001 · Cited by 1,920
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Cancer—Principles & Practice of Oncology
Rhoads, J. E. (1983) · PubMed Central · Cited by 1,466
Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 1,001
Drug Facts and Comparisons 1991.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-823_1 · Cited by 776
Hutten, B. A., Prins, M. H., Gent, M., Ginsberg, J., Tijssen, J. G. P., & Büller, H. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3078 · Cited by 748
"Compendium of pharmaceuticals and specialties".
Krogh, C. (1983) · PubMed · Cited by 411
Medical Research Council Lung Cancer Working Party*, Bleehen, N., Girling, D., Machin, D., & Stephens, R. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.196 · Cited by 274
TRANEXAMIC ACID FOR CONTROL OF HAEMORRHAGE IN ACUTE PROMYELOCYTIC LEUKAEMIA
Avvisati, G., Büller, H., Cate, J., & Mandelli, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90181-5 · Cited by 264
Cited by
Peris, K., Fargnoli, M. C., Kaufmann, R., Arenberger, P., Bastholt, L., Seguin, N. B., Bataille, V., Brochez, L., del Marmol, V., Dummer, R., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113254 · Cited by 308
Bakos, O., Lawson, C., Rouleau, S., & Tai, L.-H. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0398-7 · Cited by 192
Metadata
- Authors
- Pereira, J., & Phan, T.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09-01
- Volume
- 9
- Issue
- 5
- Pages
- 561-570
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2133116306
- Cited by
- 323
- References
- 34
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of Bleeding in Patients with Advanced Cancer. https://app.cochat.ai/papers/10.1634/theoncologist.9-5-561
- The paper
- Pereira, J., & Phan, T. (2004). Management of Bleeding in Patients with Advanced Cancer. The Oncologist. https://doi.org/10.1634/theoncologist.9-5-561
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
